FDA Warnings: Mariposa Done With OTCs, Thibiant's Long Correction List
Executive Summary
GMP violations FDA inspectors found at Mariposa Labs' plant were repeats of a previous inspection. Thibiant International's problems included was "knowing the formulation was flawed" but making "a second batch using the same formulation."
You may also be interested in...
Scientific Solutions Global's Formulations Miss OTC Monographs Mark – FDA
Firms' BioTemper, bare and Urea brand products, as formulated and labeled, are unapproved drugs that need approval through NDAs before being sold in US, FDA says in warning. Separate websites firm operates for each brand continues offering sales.
CBD Oral Sprays For Pain, Sleep, Weight Recalled On Microbial Contamination
First report of salmonella contamination for a kratom supplement in nearly nine months prompts Sunstone Organics to recall one lot each of its white vein and maeng da types of the herb. FDA's latest recall database update includes Nutrafuels' recall of more than 1,500 of its CTFO Oral Spray with pure CBD hemp oil isolate dietary supplements for sleep support, weight loss and pain relief after third-party testing showed microbial contamination.
Warnings Up As FDA Trims Its List Of Uninspected OTC Drug Manufacturers
Hundreds of foreign OTC drug firms marketing products in US had not been inspected for GMP compliance before FDA Safety and Innovation Act of 2012 pointed agency toward crossing those facilities off its list. Of the foreign OTC facilities inspected between June 2016 and January 2018, 25% received "official action indicated" inspection results, prompting warning letters and import alerts.